Skip to main content

Advertisement

Log in

Total body irradiation-containing conditioning regimens without antithymocyte globulin in adults with aplastic anemia undergoing umbilical cord blood transplantation

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

Thus far, there have been no large cohort studies on total body irradiation (TBI)-containing conditioning regimens without antithymocyte globulin (ATG) in adults with aplastic anemia (AA) undergoing umbilical cord blood (UCB) transplantation (UCBT). We retrospectively analyzed 115 adults with idiopathic AA undergoing UCBT using TBI-containing reduced-intensity conditioning (RIC) regimens without ATG between 2000 and 2018 on behalf of the Adult Aplastic Anemia Working Group of the Japanese Society for Hematopoietic Cell Transplantation. We then compared transplantation outcomes between a fludarabine (Flu)- and melphalan (Mel)-based regimen (FM) and a Flu- and cyclophosphamide (Cy)-based regimen (FC). The median patient age at UCBT was 41 years. The median total nucleated cell and total CD34+ cell doses in a UCB unit at cryopreservation were 2.5 × 107/kg and 0.7 × 105/kg, respectively. The median follow-up period for survivors was 47 months. The cumulative incidence rate of neutrophil engraftment was 76.5%, and the 4-year overall survival (OS) rate was 64.3%. In multivariate analysis, the covariates that were significantly associated with a higher neutrophil engraftment were total CD34+ cell dose in an UCB unit (≥ 0.7 × 105/kg; hazard ratio, 0.57, P = 0.01) and total dose of TBI (4 Gy of TBI; hazard ratio, 0.32, P = 0.01). There was no significant difference in the cumulative incidence of neutrophil engraftment and the 4-year OS between the FM and FC groups. In conclusion, TBI-containing RIC regimens without ATG are suitable for adults with AA undergoing UCBT. There were no significant differences in transplantation outcomes between the FM and FC groups.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Bacigalupo A (2018) Alternative donor transplants for severe aplastic anemia. Hematol Am Soc Hematol Educ Program 2018:467–473. https://doi.org/10.1182/asheducation-2018.1.467

    Article  Google Scholar 

  2. Peffault de Latour R (2016) Transplantation for bone marrow failure: current issues. Hematol Am Soc Hematol Educ Program 2016:90–98. https://doi.org/10.1182/asheducation-2016.1.90

    Article  Google Scholar 

  3. Peffault de Latour R, Purtill D, Ruggeri A, Sanz G, Michel G, Gandemer V, Maury S, Kurtzberg J, Bonfim C, Aljurf M, Gluckman E, Socié G, Passweg J, Rocha V (2011) Influence of nucleated cell dose on overall survival of unrelated cord blood transplantation for patients with severe acquired aplastic anemia: a study by eurocord and the aplastic anemia working party of the European group for blood and marrow transplantation. Biol Blood Marrow Transplant 17:78–85. https://doi.org/10.1016/j.bbmt.2010.06.011

    Article  PubMed  Google Scholar 

  4. Yoshimi A, Kojima S, Taniguchi S, Hara J, Matsui T, Takahashi Y, Azuma H, Kato K, Nagamura-Inoue T, Kai S, Kato S, Network JCBB, (JCBBN), (2008) Unrelated cord blood transplantation for severe aplastic anemia. Biol Blood Marrow Transplant 14:1057–1063. https://doi.org/10.1016/j.bbmt.2008.07.003

    Article  PubMed  CAS  Google Scholar 

  5. Kuwatsuka Y, Kanda J, Yamazaki H, Mori T, Miyamura K, Kako S, Uchida N, Ohashi K, Ozawa Y, Takahashi Y, Kato C, Iwato K, Ishiyama K, Kobayashi H, Eto T, Kahata K, Kato J, Miyamoto T, Kato K, Mori S, Atsuta Y, Kimura F, Kanda Y, Japan Society for Hematopoietic Cell Transplantation (2016) A comparison of outcomes for cord blood transplantation and unrelated bone marrow transplantation in adult aplastic anemia. Biol Blood Marrow Transplant 22:1836–1843. https://doi.org/10.1016/j.bbmt.2016.07.002

    Article  PubMed  Google Scholar 

  6. Kudo K, Muramatsu H, Narita A, Yoshida N, Kobayashi R, Yabe H et al (2017) Unrelated cord blood transplantation in aplastic anemia: is anti-thymocyte globulin indispensable for conditioning? Bone Marrow Transplant 52:1659–1661. https://doi.org/10.1038/bmt.2017.169

    Article  PubMed  CAS  Google Scholar 

  7. Pascal L, Tucunduva L, Ruggeri A, Blaise D, Ceballos P, Chevallier P, Cornelissen J, Maillard N, Tabrizi R, Petersen E, Linkesch W, Sengeloev H, Kenzey C, Pagliuca A, Holler E, Einsele H, Gluckman E, Rocha V, Yakoub-Agha I, Eurocord and the European Society for Blood and Marrow Transplantation (2015) Impact of ATG-containing reduced-intensity conditioning after single- or double-unit allogeneic cord blood transplantation. Blood 126:1027–1032. https://doi.org/10.1182/blood-2014-09-599241

    Article  PubMed  CAS  Google Scholar 

  8. Yamamoto H, Kato D, Uchida N, Ishiwata K, Araoka H, Takagi S, Nakano N, Tsuji M, Asano-Mori Y, Matsuno N, Masuoka K, Izutsu K, Wake A, Yoneyama A, Makino S, Taniguchi S (2011) Successful sustained engraftment after reduced-intensity umbilical cord blood transplantation for adult patients with severe aplastic anemia. Blood 117:3240–3242. https://doi.org/10.1182/blood-2010-08-295832

    Article  PubMed  CAS  Google Scholar 

  9. Ochi T, Onishi Y, Nasu K, Onodera K, Kobayashi M, Ichikawa S, Fujiwara T, Fukuhara N, Yamada-Fujiwara M, Harigae H (2019) Umbilical cord blood transplantation using reduced-intensity conditioning without antithymocyte globulin in adult patients with severe aplastic anemia. Biol Blood Marrow Transplant 25:e55–e59. https://doi.org/10.1016/j.bbmt.2018.09.039

    Article  PubMed  Google Scholar 

  10. Terakura S, Nishida T, Inamoto Y, Ohashi H, Naoe T, Murata M (2014) Successful unrelated cord blood transplantation for adult acquired aplastic anemia using reduced intensity conditioning without ATG. Immunol Lett 160:99–101. https://doi.org/10.1016/j.imlet.2014.01.013

    Article  PubMed  CAS  Google Scholar 

  11. Atsuta Y, Suzuki R, Yoshimi A, Gondo H, Tanaka J, Hiraoka A, Kato K, Tabuchi K, Tsuchida M, Morishima Y, Mitamura M, Kawa K, Kato S, Nagamura T, Takanashi M, Kodera Y (2007) Unification of hematopoietic stem cell transplantation registries in Japan and establishment of the TRUMP System. Int J Hematol 86:269–274. https://doi.org/10.1532/IJH97.06239

    Article  PubMed  Google Scholar 

  12. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty HG, Hows J et al (1994) Bone Marrow Transplant 1995; 15 Consens Conference on acute GVHD grading, pp 825–828

  13. Sullivan KM, Agura E, Anasetti C, Appelbaum F, Badger C, Bearman S, Erickson K, Flowers M, Hansen J, Loughran T et al (1991) Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol 28:250–259

    PubMed  CAS  Google Scholar 

  14. Giralt S, Ballen K, Rizzo D, Bacigalupo A, Horowitz M, Pasquini M, Sandmaier B (2009) Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research. Biol Blood Marrow Transplant 15:367–369. https://doi.org/10.1016/j.bbmt.2008.12.497

    Article  PubMed  PubMed Central  Google Scholar 

  15. Gooley TA, Leisenring W, Crowley J, Storer BE (1999) Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 18:695–706. https://doi.org/10.1002/(sici)1097-0258(19990330)18:6%3c695::aid-sim60%3e3.0.co;2-o

    Article  PubMed  CAS  Google Scholar 

  16. Cox DR (1972) Regression models and life-tables. J R Stat Soc 34:187–202. https://doi.org/10.1111/j.2517-6161.1972.tb00899.x

    Article  Google Scholar 

  17. Fine T, Gray RJ (1999) Self-consistency and principal component analysis. J Am Stat Assoc 94:456–467. https://doi.org/10.1080/01621459.1999.10474140

    Article  Google Scholar 

  18. Kanda Y (2013) Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant 48:452–458. https://doi.org/10.1038/bmt.2012.244

    Article  PubMed  CAS  Google Scholar 

  19. Wakamatsu M, Terakura S, Ohashi K, Fukuda T, Ozawa Y, Kanamori H, Sawa M, Uchida N, Ota S, Matsushita A, Kanda Y, Nakamae H, Ichinohe T, Kato K, Murata M, Atsuta Y, Teshima T (2019) GVHD Working Group of the Japan Society for Hematopoietic Cell Transplantation (2019) Impacts of in patients with acute leukemia in remission undergoing allogeneic HSCT from different donors. Blood Adv 3:105–115

    Article  CAS  Google Scholar 

  20. Peffault de Latour R, Chevret S, Jubert C, Sirvent A, Galambrun C, Ruggeri A, Gandemer V, Cornillon J, Rialland F, Dalle JH, Forcade E, Bruno B, Paillard C, Rorlich PS, Salmon A, Fürst S, Sicre de Fontbrune F, Rubio MT, Bay JO, Mohty M, Larghero J, Gluckman E, Socié G, Francophone Society of Bone Marrow Transplantation and Cellular Therapy (2018) Unrelated cord blood transplantation in patients with idiopathic refractory severe aplastic anemia: a nationwide phase 2 study. Blood 132:750–754. https://doi.org/10.1182/blood-2018-01-829630

    Article  PubMed  CAS  Google Scholar 

  21. Deeg HJ, O’Donnell M, Tolar J, Agarwal R, Harris RE, Feig SA, Territo MC, Collins RH, McSweeney PA, Copelan EA, Khan SP, Woolfrey A, Storer B (2006) Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy. Blood 108:1485–1491. https://doi.org/10.1182/blood-2006-03-005041

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  22. Bacigalupo A, Socie’ G, Lanino E, Prete A, Locatelli F, Locasciulli A, Cesaro S, Shimoni A, Marsh J, Brune M, Van Lint MT, Oneto R, Passweg J, Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation (2010) Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA Working Party. Haematologica 95:976–982. https://doi.org/10.3324/haematol.2009.018267

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  23. Koh LP, Koh MB, Ng HY, Hwang WYK, Goh YT, Linn YC, Ng HJ, Chuah CT, Tan KW, Loh YS, Tan DC, Tan PH, Tan PH (2006) Allogeneic hematopoietic stem cell transplantation for patients with severe aplastic anemia following nonmyeloablative conditioning using 200-cGy total body irradiation and fludarabine. Biol Blood Marrow Transplant 12:887–890. https://doi.org/10.1016/j.bbmt.2006.04.005

    Article  PubMed  CAS  Google Scholar 

  24. Konuma T, Kato S, Oiwa-Monna M, Tanoue S, Ogawa M, Isobe M, Tojo A, Takahashi S (2017) Cryopreserved CD34+ cell dose, but not total nucleated cell dose, influences hematopoietic recovery and extensive chronic graft-versus-host disease after single-unit cord blood transplantation in adult patients. Biol Blood Marrow Transplant 23:1142–1150. https://doi.org/10.1016/j.bbmt.2017.03.036

    Article  PubMed  CAS  Google Scholar 

  25. Sanz J, Montesinos P, Saavedra S, Lorenzo I, Senent L, Planelles D, Larrea L, Martín G, Palau J, Jarque I, Martínez J, de la Rubia J, Moscardó F, Martinez D, Gómez I, López M, Sanz MA, Sanz GF (2010) Single-unit umbilical cord blood transplantation from unrelated donors in adult patients with chronic myelogenous leukemia. Biol Blood Marrow Transplant 16:1589–1595. https://doi.org/10.1016/j.bbmt.2010.05.014

    Article  PubMed  Google Scholar 

  26. Lemarie C, Esterni B, Calmels B, Dazey B, Lapierre V, Lecchi L, Meyer A, Rea D, Thuret I, Chambost H, Curtillet C, Chabannon C, Michel G (2007) CD34(+) progenitors are reproducibly recovered in thawed umbilical grafts, and positively influence haematopoietic reconstitution after transplantation. Bone Marrow Transplant 39:453–460. https://doi.org/10.1038/sj.bmt.1705618

    Article  PubMed  CAS  Google Scholar 

  27. Kuwatsuka Y, Atsuta Y, Horowitz MM, Inagaki J, Kanda J, Kato K, Koh K, Zhang MJ, Eapen M, Center for International Blood and Marrow Transplant Research (CIBMTR), and Donor/Source and GVHD Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT) (2014) Graft-versus-host disease and survival after cord blood transplantation for acute leukemia: a comparison of Japanese versus White populations. Biol Blood Marrow Transplant 20:662–667. https://doi.org/10.1016/j.bbmt.2014.01.020

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank all physicians and data managers at the centers who contributed to gathering transplantation data from the TRUMP. We also appreciate the contribution of the members of the Data Management Committees of the Japan Society for Hematopoietic Cell Transplantation.

On behalf of the Adult Aplastic Anemia Working Group of the Japanese Society for Hematopoietic Cell Transplantation

Funding

This study was supported in part by the Practical Research Project for Allergic Disease and Immunology (Research Technology of Medical Transplantation), Japan Agency for Medical Research and Development (AMED).

Author information

Authors and Affiliations

Authors

Consortia

Contributions

NH, HY, RS, YO, and TM designed the study. NH performed statistical analyses and wrote the manuscript. NU, MM, TK, SY, TE, AN, and TK provided patient data. TI and YA collected patient data. All authors interpreted the data, and reviewed and approved the final manuscript.

Corresponding author

Correspondence to Nobuhiro Hiramoto.

Ethics declarations

Ethics approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.

Consent to participate

Informed consent was obtained from all participants included in the study.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (XLSX 15 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hiramoto, N., Yamazaki, H., Nakamura, Y. et al. Total body irradiation-containing conditioning regimens without antithymocyte globulin in adults with aplastic anemia undergoing umbilical cord blood transplantation. Ann Hematol 101, 165–175 (2022). https://doi.org/10.1007/s00277-021-04664-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-021-04664-z

Keywords

Navigation